HealthPROMISE is a prescribed mobile application that assesses the impact of electronic patient reported outcomes (ePROs) on improving patients' quality of life (QoL). The recurrent nature of IBD makes affected patients ideal candidates for ePRO monitoring that centers on enhanced symptom tracking and improved communication with care teams. More specifically, patients using HealthPROMISE could update their ePRO information and receive a disease summary. Patients could also communicate over the app and discuss results with providers.